Pharmacy Times December 14, 2021
Paige Clark, RPh

Technology, COVID-19, and scope expansion—here’s how pharmacists can capitalize on opportunities coming in the new year.

It may seem like folly to try to predict the future; however, if the COVID-19 era has taught us anything, it’s that things can rapidly change. But it’s always a good idea to be prepared for whatever may come next. If I had some kind of “Magic 8 ball” for pharmacists in 2022, here’s what it would say.

1. Prepare for the continuing expansion of scope to meet public health outcomes

Nobody can argue that pharmacists are among the most trusted medical professionals. And with 90% of Americans living within 5 miles of a pharmacy, we are also some of the most accessible, supporting...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Novartis to acquire radiopharmaceutical firm Mariana Oncology for up to $1.75B
Amgen shares soar as executives outline obesity drug push
A closer look at 2023's top biopharma deals and what lies ahead
Amid buzz for Amgen's obesity drug, company sees revenue boost
Fierce Pharma Asia—Ono buys Deciphera for $2.4B; Novartis expands PeptiDream collab; WuXi Bio exits BIO 2024

Share This Article